Position in ABBV
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$2,993,509
+$449,746 QoQ
Shares Held
11,896
+1.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
#1,655
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ipswich Investment Management Co., Inc. holds $39,266,096 across 11 Drug Manufacturers - General names. ABBV ranks #5 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
37,293 | $9,471,303 | |
| 2 | LLY |
ELI LILLY & Co
|
6,727 | $8,068,566 | |
| 3 | MRK |
Merck & Co., Inc.
|
46,912 | $6,028,192 | |
| 4 | AMGN |
Amgen Inc
|
15,234 | $5,516,536 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
11,896 | $2,993,509 | |
| 6 | NVS |
Novartis AG
|
16,585 | $2,599,201 | |
| 7 | NVO |
Novo Nordisk A S
|
50,411 | $2,416,703 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
17,229 | $992,734 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,993,509 | 11,896 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $2,543,763 | 11,696 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $2,440,044 | 10,679 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $2,473,773 | 10,684 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $2,178,807 | 11,738 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $3,030,287 | 14,463 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $2,985,004 | 16,798 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $3,554,245 | 17,998 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $6,457,384 | 37,648 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $6,864,805 | 37,698 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $5,857,556 | 37,798 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $5,634,169 | 37,798 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $5,173,362 | 38,398 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $6,148,175 | 38,578 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $6,148,129 | 38,043 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $5,104,140 | 38,031 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $5,869,244 | 38,321 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $6,547,136 | 40,387 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $5,429,133 | 40,097 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $4,197,976 | 38,917 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $4,370,094 | 38,797 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $4,252,721 | 39,297 | Shares | Sole | 2021-04-09 | |
| 2020-12-31 | $4,232,103 | 39,497 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $3,438,783 | 39,260 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $3,871,728 | 39,435 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $2,960,667 | 38,859 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||